Thoratec Corp. (THOR)
-NasdaqGS 38.02 
0.28(0.73%) 3:23PM EDT - Nasdaq Real Time Price
| Prev Close: | 38.30 |
|---|
| Open: | 38.07 |
|---|
| Bid: | 38.16 x 400 |
|---|
| Ask: | 38.18 x 200 |
|---|
| 1y Target Est: | 40.92 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | 28-Oct-13 |
|---|
| Day's Range: | 37.44 - 38.60 |
|---|
| 52wk Range: | 29.91 - 39.86 |
|---|
| Volume: | 560,170 |
|---|
| Avg Vol (3m): | 603,242 |
|---|
| Market Cap: | 2.19B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Bulls can't get enough of ThoratecoptionMONSTER(Mon, Sep 30)
- [video] Fast Money Final Tradeat CNBC(Wed, Sep 25)
- Your first trade for Thursdayat CNBC(Wed, Sep 25)
- [video] Dow closes around lows of sessionat CNBC(Tue, Sep 24)
- [video] Stocks show afternoon weaknessat CNBC(Tue, Sep 24)
- [video] Closing Bell Exchangeat CNBC(Tue, Sep 24)
- Thoratec Upped to NeutralZacks(Fri, Sep 20)
- Thoratec shares undervalued, says Oppenheimerat theflyonthewall.com(Tue, Sep 17)
- Buffett’s investing advice is a portfolio killerat MarketWatch(Thu, Sep 12)
- HeartWare Might Have Missed The Boat: A Hedging Strategyat Seeking Alpha(Mon, Sep 9)
- THORATEC CORP Files SEC form 8-K/A, Financial Statements and ExhibitsEDGAR Online(Thu, Sep 5)
- THOR Crosses Below Key Moving Average Levelat Forbes(Tue, Sep 3)
- So You Have Some Questions About Sunshine Heart?at Seeking Alpha(Fri, Aug 30)
- Sunshine Heart To Go Head To Head With Thoratec In NYHA Class III CHF Trialsat Seeking Alpha(Tue, Aug 27)
- Sunshine Heart Inc.: A Sleeping Giantat Seeking Alpha(Thu, Aug 22)
Key Statistics
| Forward P/E (1 yr): | 19.88 |
|---|
| P/S (ttm): | 4.46 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.75 |
|---|
| Quarterly EPS Est
(Sep-13)
: | 0.40 |
|---|
| Mean Recommendation*: | 2.1 |
|---|
| PEG Ratio (5 yr expected): | 2.26 |
|---|
Business Summary
Thoratec Corporation engages in the development, manufacture, and marketing of proprietary medical devices used for circulatory support. The companys primary product lines include ventricular assist devices, such as HeartMate II, an implanta...
View More